Gene: KIF16B
Official Full Name: kinesin family member 16Bprovided by HGNC
Gene Summary: The protein encoded by this gene is a kinesin-like protein that may be involved in intracellular trafficking. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16727 | KIF16B Knockout cell line (HeLa) | Human | KIF16B | 1:3~1:6 | Negative | Online Inquiry |
KO16728 | KIF16B Knockout cell line (HCT 116) | Human | KIF16B | 1:2~1:4 | Negative | Online Inquiry |
KO16729 | KIF16B Knockout cell line (HEK293) | Human | KIF16B | 1:3~1:6 | Negative | Online Inquiry |
KO16730 | KIF16B Knockout cell line (A549) | Human | KIF16B | 1:3~1:4 | Negative | Online Inquiry |
KIF16B Gene Knockout Cell Lines are specialized cellular models that enable the study of the kinesin superfamily member KIF16B, an essential molecular motor involved in intracellular transport within eukaryotic cells. By employing CRISPR-Cas9 gene editing technology, these cell lines have been meticulously engineered to disrupt the expression of the KIF16B gene, facilitating researchers in understanding the functional roles of this protein in cellular processes.
The key mechanism underlying the function of KIF16B is its ability to transport organelles, proteins, and cellular cargos along microtubules, utilizing the energy derived from ATP hydrolysis. With the knockout of KIF16B, researchers can create a loss-of-function model that elucidates its involvement in events ranging from vesicle trafficking to cell division, thereby providing vital insights into the pathophysiology of various diseases associated with cellular transport abnormalities.
The scientific importance of KIF16B Gene Knockout Cell Lines extends into both basic and applied research. In basic science, they serve as pivotal tools for dissecting molecular pathways and understanding the implications of KIF16B dysregulation in disorders such as neurodegenerative diseases and cancer. Clinically, these models hold promise in drug discovery and development, enabling the screening of potential therapeutics aimed at modulating KIF16B-related pathways.
What sets these cell lines apart from traditional models is their precision and reliability in simulating KIF16B deficiency. Compared to alternatives that may introduce confounding variables, our knockout cell lines provide a clean and defined genetic background, ensuring reproducibility of results. Additionally, backed by our versatile cryopreservation techniques, researchers can easily store and maintain these lines, facilitating long-term studies.
Valuable to academic researchers and clinical laboratories alike, KIF16B Gene Knockout Cell Lines are indispensable for anyone seeking to unravel the complexities of intracellular transport and its implications in health and disease. Our company, with its commitment to innovation and quality in biological products, is dedicated to supporting scientific advancement through these advanced cellular tools.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.